Spectrum of AIDS-associated malignant disorders

Lancet

Volumn 351, Issue 9119, 1998, Pages 1833-1839

  Goedert, James J ^a,d   Coté, Timothy R ^a   Virgo, Phillip ^b   Scoppa, Steven M ^c   Kingma, Douglas W ^a   Gail, Mitchell H ^a   Jaffe, Elaine S ^a   Biggar, Robert J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Computer Sciences Corporation ^*  (United States)

^c INFORMATION MANAGEMENT SERVICES INC   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ALGORITHM; ANGIOSARCOMA; ARTICLE; BRAIN CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CIGARETTE SMOKING; FEMALE; HERPES; HODGKIN DISEASE; HUMAN; INCIDENCE; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; PUERTO RICO; RISK FACTOR; SEMINOMA; SEXUAL BEHAVIOR; TECHNIQUE; UNITED STATES; VIRUS INFECTION;

EID: 0032551162     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)09028-4     Document Type: Article

References (37)

1. 1 Kinlen LJ. Immunological factors, including AIDS. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention, 2nd edin. New York: Oxford University Press, 1996: 532-45.
2. 2 IARC monographs on the evaluation of carcinogenic risks to humans: human immunodeficiency viruses and human T-cell lymphotropic viruses, vol 67. France: Lyon, 1996.
3. 3 Centers for Disease Control and Prevention. HIV/AIDS surveillance report, 1996; 8: 18.
4. 4 Coté TR, O'Brien TR, Ward JW, Wilson SE, Blattner WA. AIDS and cancer registry linkage: measurement and enhancement of registry completeness: The National AIDS/Cancer Match Study Group. Prev Med 1995; 24: 375-77.
5. 5 Kingma DW, Medeiros LJ, Barletta J, et al. Epstein-Barr virus is infrequently identified in non-Hodgkin's lymphomas associated with Hodgkin's disease. Am J Surg Pathol 1994; 18: 48-61.
6. 6 Percy C, VanHolten V, Muir C, eds. International classification diseases for oncology, 2nd edn. Geneva: WHO, 1990.
7. 7 Ries LAG, eds. SEER cancer statistics review, 1973-1991: tables and graphs. NIH publication number 94-2789, Bethesda, MD, USA, 1994.
8. 8 Biggar RJ, Rosenberg PS, Coté TR. Kaposi's sarcoma and non-Hodgkin's lymphoma following the diagnosis of AIDS: The Multistate AIDS/Cancer Match Study Group. Int J Cancer 1996; 68: 754-58.
9. 9 Melbye M, Coté TR, Kessler L, Gail M, Biggar RJ. High incidence of anal cancer among AIDS patients. Lancet 1994; 343: 636-39.
10. 10 Goedert JJ, Coté TR. Conjunctival malignant disease with AIDS in USA Lancet 1995; 346: 257-58.
11. 11 McClain KL, Leach CT, Jenson HB, et al. Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS. N Engl J Med 1995; 332: 12-18.
12. 12 Kingma DW, Shad A, Tsokos M, et al. Epstein-Barr virus (EBV)-associated smooth-muscle tumor arising in a post-transplant patient treated successfully for two PT-EBV-association large-cell lymphomas: case report. Am J Surg Pathol 1996; 20: 1511-19.
13. 13 Fizazi K, Feuillard J, Le Cesne A, et al. Soft-tissue sarcomas in HIV-infected adult patients. Eur J Cancer 1996; 32A: 1812-14.
14. 14 Mueller NE. Hodgkin's disease. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention, 2nd edition. New York: Oxford University Press, 1996: 893-919.
15. 15 Mueller N, Evans A, Harris NL, et al. Hodgkin's disease and Epstein-Barr virus: altered antibody pattern before diagnosis. N Engl J Med 1989; 320: 689-95.
16. 16 Dictor M, Attewell R. Epidemiology of Kaposi's sarcoma in Sweden prior to the acquired immunodeficiency syndrome. Int J Cancer 1988; 42: 346-51.
17. 17 Biggar RJ, Curtis RE, Coté TR, Rabkin CS, Melbye M. Risk of other cancers following Kaposi's sarcoma: relation to acquired immunodeficiency syndrome. Am J Epidemiol 1994; 139: 362-68.
18. 18 Lyter DW, Kingsley LA, Rinaldo CR, Bryant J. Malignancies in the multicenter AIDS cohort study (MACS), 1984-1994. Proc Annu Meet Am Soc Clin Oncol 1996; 15: 852 (abstr).
19. 19 Moore PS, Gao SJ, Dominguez G, et al. Primary characterization of a herpesvirus agent associated with Kaposi's sarcoma. J Virol 1996; 70: 549-58.
20. 20 Rettig MB, Ma HJ, Vescio RA, et al. Kaposi's sarcoma-associated herpesvirus infection of bone-marrow dendritic cells from multiple myeloma patients. Science 1997; 276: 1851-54.
21. 21 Nicholas J, Ruvolo VR, Burns WH, et al. Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med 1997; 3: 287-92.
22. 22 Bataille R, Harousseau J-L. Multiple myeloma. N Engl J Med 1997; 336: 1657-64.
23. 23 Parravicini C, Lauri E, Baldini L, et al. Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma [letter]. Science 1997; 278: 1969-70.
24. 24 Lyter DW, Bryant J, Thackeray R, Rinaldo CR, Kingsley LA. Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men. J Clin Oncol 1995; 13: 2540-46.
25. 25 Curtis RE, Rowlings PA, Deeg HJ, et al. Solid cancers after bone marrow transplantation. N Engl J Med 1997; 336: 897-904.
26. 26 Ammann AJ. Hypothesis: absence of graft-versus-host disease in AIDS is a consequence of HIV-1 infection of CD+ T-cells. J Acquir Immune Defic Syndr Hum Retrovirol 1993; 6: 1224-27.
27. 27 Mueller N, Hinkula J, Wahren B. Elevated antibody titers against cytomegalovirus among patients with testicular cancer. Int J Cancer 1988; 41: 399-403.
28. 28 Heinzer H, Dieckmann KP, Huland E. Virus-related serology and in-situ hybridization for the detection of virus DNA among patients with testicular cancer. Eur Urol 1993; 24: 271-76.
29. 29 Arthur RR, Grossman SA, Ronnett BM, Bigner SH, Vogelstein B, Shah KV Lack of association of human polyomaviruses with human brain tumors. J Neurooncol 1994; 20: 55-58.
30. 30 IARC monographs on the evaluation of carcinogenic risks to humans: human papillomaviruses, vol 64. France: Lyon, 1995.
31. 31 Day NE, Walter SD. Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. Biometrics 1984; 40: 1-14.
32. 32 Gao SJ, Kingsley L, Hoover DR, et al. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996; 335: 233-41.
33. 33 Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 1996; 2: 918-24.
34. 34 IARC monographs on the evaluation of carcinogenic risks to humans: Epstein-Barr virus and human herpesvirus 8, vol 70. France: Lyon, 1998.
35. 35 Yu MC, Henderson BE. Nasopharyngeal cancer. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention, 2nd edn. New York: Oxford University Press, 1996: 603-18.
36. 36 Melbye M, Coté TR, West D, Kessler L, Biggar RJ. Nasopharyngeal carcinoma: an EBV-associated tumour not significantly influenced by HIV-induced immunosuppression: The AIDS/Cancer Working Group. Br J Cancer 1996; 73: 995-97.
37. 37 London WT, McGlynn KA. Liver cancer. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention, 2nd edn. New York: Oxford University Press, 1996: 772-93.